Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Ulcerative Colitis (UC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04294615
What this trial is testing

Clinical Response and Safety Following FMT for UC

Who this might be right for
Inflammatory Bowel DiseasesFecal Microbiota Transplantation
Air Force Military Medical University, China 9
Early research (Phase 1)Looking for participantsNCT05786404
What this trial is testing

Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis

Who this might be right for
Active Ulcerative Colitis (UC)
The University of Texas Health Science Center, Houston 20
Not applicableUnknownNCT03408847
What this trial is testing

Monocultivar Coratina Extra Virgin Olive Oil in UC Patients

Who this might be right for
Ulcerative Colitis Chronic Mild
Casa Sollievo della Sofferenza IRCCS 30
Early research (Phase 1)Study completedNCT04254783
What this trial is testing

Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative Colitis (UC)Crohn's Disease
AbbVie 20
Not applicableStudy completedNCT03173144
What this trial is testing

Chronic Inflammatory Disease, Lifestyle and Treatment Response

Who this might be right for
Autoimmune DiseasesInflammatory Bowel DiseasesCrohn Disease (CD)+7 more
University of Southern Denmark 233
Large-scale testing (Phase 3)Ended earlyNCT05644665
What this trial is testing

Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 131
Not applicableActive Not RecruitingNCT01848561
What this trial is testing

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 8,250
Testing effectiveness (Phase 2)Looking for participantsNCT06979336
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Genentech, Inc. 224
Testing effectiveness (Phase 2)Looking for participantsNCT07080034
What this trial is testing

Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Biocad 198
Not applicableNot Yet RecruitingNCT07705126
What this trial is testing

A National Multicenter Study of Etrasimod for the Treatment of Patients With Active UC

Who this might be right for
Ulcerative Colitis (UC)
Tang-Du Hospital 500
Testing effectiveness (Phase 2)Study completedNCT05291689
What this trial is testing

A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC

Who this might be right for
Inflammatory Bowel DiseasesColitis, Ulcerative
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) 39
Testing effectiveness (Phase 2)Ended earlyNCT04987307
What this trial is testing

Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Amgen 221
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07755241
What this trial is testing

AC-101 Tablets in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Accro Bioscience (Suzhou) Limited 153
Not applicableNot Yet RecruitingNCT07637045
What this trial is testing

Urinary PGE-MUM as a Marker for Ulcerative Colitis Activity

Who this might be right for
Ulcerative Colitis (UC)
Assiut University 114
Early research (Phase 1)Study completedNCT05975047
What this trial is testing

LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Liveome Inc. 38
Testing effectiveness (Phase 2)Study completedNCT04504383
What this trial is testing

PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis Chronic ModerateUlcerative Colitis Chronic Severe
Protagonist Therapeutics, Inc. 169
Large-scale testing (Phase 3)UnknownNCT06274294
What this trial is testing

Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC

Who this might be right for
Inflammatory Bowel Diseases
CMC Ambroise Paré 130
Testing effectiveness (Phase 2)Ended earlyNCT06137183
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Genentech, Inc. 79
Large-scale testing (Phase 3)Study completedNCT02819635
What this trial is testing

Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 1,302
Large-scale testing (Phase 3)Study completedNCT02368717
What this trial is testing

An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase

Who this might be right for
Ulcerative Colitis
Ferring Pharmaceuticals 281
Next Page